Biolife Solutions Inc
BLFS- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0000834365
No open-market purchases or sales by Biolife Solutions Inc insiders were filed in the last 90 days; 216 institutions reported holding it in 13F filings for Q2 2026, worth $1.40B in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Biolife Solutions Inc changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 160 | 174 | +14 |
| Shares | 36.9M | 38.4M | +1.56M (+4.2%) |
| Value | $509.1M | $873.9M | +$364.7M (+71.6%) |
New holders (23)
Institutions that held Biolife Solutions Inc at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (9)
Institutions that held Biolife Solutions Inc at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Renaissance Technologies LLC | 179,200 | $2.48M |
| HighTower Advisors, LLC | 93,767 | $1.29M |
| Qube Research & Technologies Ltd | 57,976 | $801.0K |
| Versor Investments LP | 26,300 | $363.0K |
| Two Sigma Advisers, LP | 18,800 | $260.0K |
| Simplex Trading, LLC | 567 | $7.00K |
| Aquatic Capital Management LLC | 200 | $3.00K |
| Total Clarity Wealth Management, Inc. | 235 | $3.00K |
| Prospera Financial Services Inc | 91 | $1.00K |